Lamotrigin Ratiopharm (Lamotrigine)

Lamotrigine works by blocking voltage‑gated sodium channels on neurons, which stabilises the neuronal membrane and reduces the release of excitatory neurotransmitters such as glutamate. This action decreases seizure activity and contributes to mood stabilisation.

The specific dosage regimen for Lamotrigin Ratiopharm is determined by the prescribing clinician based on the patient’s age, weight, indication, and concomitant medications. The prescriber will tailor the dose to achieve optimal therapeutic effect while minimising side‑effects.

The safety of lamotrigine in pregnancy and lactation is not fully established. It should only be used when the potential benefit to the mother outweighs any possible risk to the fetus or infant, and this decision must be made by a qualified healthcare professional.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Lamotrigine is distinguished by its dual activity as an antiepileptic and mood stabiliser, a profile not shared by many other anticonvulsants. Compared with older agents such as carbamazepine, it has a lower risk of enzyme‑inducing drug interactions but requires careful monitoring for skin reactions.

Lamotrigin Ratiopharm tablets should be stored at ambient temperature, below 25 °C, in the original packaging to protect them from moisture and light. Do not store in areas of high humidity or extreme heat.

The medication is taken orally, usually as a tablet, with or without food as directed by the prescriber. Swallow the tablet whole with water and follow the dosing schedule provided by the healthcare professional.

The most serious risks include severe skin reactions such as Stevens‑Johnson syndrome or toxic epidermal necrolysis, blood dyscrasias, and rare cases of hepatic failure. Patients should seek immediate medical attention if they develop a widespread rash or other alarming symptoms.

Lamotrigin Ratiopharm should be avoided in individuals with a known hypersensitivity to lamotrigine or any component of the formulation, and in patients with a history of severe skin reactions to anticonvulsants. Caution is also advised for those with significant hepatic impairment.